Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-287.86%
operating margin TTM
-61.03%
revenue TTM
464.50 Thousand
revenue per share TTM
0.08$
valuation ratios | |
|---|---|
| pe ratio | -0.16 |
| peg ratio | -0.00 |
| price to book ratio | -0.61 |
| price to sales ratio | 0.25 |
| enterprise value multiple | -0.18 |
| price fair value | -0.61 |
profitability ratios | |
|---|---|
| gross profit margin | 83.71% |
| operating profit margin | -61.03% |
| pretax profit margin | -66.24% |
| net profit margin | -287.86% |
| return on assets | -340.22% |
| return on equity | 373.98% |
| return on capital employed | 308.87% |
liquidity ratio | |
|---|---|
| current ratio | 0.48 |
| quick ratio | 0.40 |
| cash ratio | 0.19 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 185.11 |
| operating cycle | 189.31 |
| days of payables outstanding | 75.87 |
| cash conversion cycle | 113.44 |
| receivables turnover | 87.00 |
| payables turnover | 4.81 |
| inventory turnover | 1.97 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.40 |
| debt equity ratio | -0.45 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | -0.82 |
| interest coverage | -17.05 |
| cash flow to debt ratio | -1.57 |
cash flow ratios | |
|---|---|
| free cash flow per share | -6.45 |
| cash per share | 3.98 |
| operating cash flow per share | -6.43 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -1.57 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -279.34 |
Frequently Asked Questions
When was the last time Atara Biotherapeutics, Inc. (NASDAQ:ATRA) reported earnings?
Atara Biotherapeutics, Inc. (ATRA) published its most recent earnings results on 12-11-2024.
What is Atara Biotherapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Atara Biotherapeutics, Inc. (NASDAQ:ATRA)'s trailing twelve months ROE is 373.98%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Atara Biotherapeutics, Inc. (ATRA) currently has a ROA of -340.22%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ATRA's net profit margin stand at?
ATRA reported a profit margin of -287.86% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ATRA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.48 in the most recent quarter. The quick ratio stood at 0.40, with a Debt/Eq ratio of -0.45.